CN105462893B - Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot - Google Patents
Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot Download PDFInfo
- Publication number
- CN105462893B CN105462893B CN201510979400.6A CN201510979400A CN105462893B CN 105462893 B CN105462893 B CN 105462893B CN 201510979400 A CN201510979400 A CN 201510979400A CN 105462893 B CN105462893 B CN 105462893B
- Authority
- CN
- China
- Prior art keywords
- sophora tonkinensis
- tonkinensis gapnep
- endogenetic bacteria
- root rot
- metabolite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/10—Animals; Substances produced thereby or obtained therefrom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Pest Control & Pesticides (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of sophora tonkinensis Gapnep endogenetic bacteria B29, the classification naming of sophora tonkinensis Gapnep endophyte B29 is bulkholderia cepasea (Burkholderia sp.) B29, the 16S rDNA gene order table of bacterial strain is as described in SEQ ID NO.1, depositary institution: China Committee for Culture Collection of Microorganisms's common micro-organisms center, preservation address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3 Institute of Microorganism, Academia Sinica, preservation date: on May 13rd, 2015, deposit number: CGMCC No.10807.The present invention for the first time from the root of medicinal plant sophora tonkinensis Gapnep separation screening to one plant of endogenetic bacteria (Burkholderia sp.) B29, the bacterium has very strong inhibiting effect to notoginseng root rot bacterium, brings wide application prospect for the field of biological control of Radix Notoginseng fungal disease.
Description
Technical field
The present invention relates to field of biotechnology, in particular to a kind of sophora tonkinensis Gapnep endogenetic bacteria B29 is in prevention and treatment notoginseng root rot
In application.
Background technique
Modern agriculture is overly dependent upon the use of chemical pesticide to the prevention and treatment of plant disease, and the release of a large amount of chemical pesticides is not
Only there is long-term destruction to ecological environment, also quality of agricultural product is caused to decline, excessive pesticide residues, the drug resistance of pathogen
Property and to problems such as people and animals' nocuousness.It finds safer, effective pest control method to be of great significance, utilize
The method of biology, which carrys out controlling plant diseases, effectively to solve the above problems.
Radix Notoginseng (Panax notoginseng F.H.chen) also known as pseudo-ginseng, invaluable etc., have significant activating microcirculation and removing stasis medicinal,
Detumescence ding-tong effect is a kind of Chinese tradition rare medicinal herbs.Using Radix Notoginseng as Chinese patent drug made of primary raw material such as " Yunnan Baiyao "
" Pien Tze Huang " etc. is wide-spread.In recent years, the demand to Radix Notoginseng raw material is growing.But the nosomycosis in cultivation
Evil has seriously affected Panax notoginseng Growth.Currently, prevention and treatment fungal disease depends on chemical pesticide unduly on notoginseng planting, a large amount of chemistry
The use of pesticide not only affects the quality of Radix Notoginseng, also results in a large amount of pesticide residues of pseudo-ginseng.
Notoginseng root rot is one of Radix Notoginseng Major Diseases, is commonly called as " green smelly " in producing region, cardinal symptom be seedling stage bud-rot and
The water stain shape lesion of brown of its reed head and bastem junction is until spread to entire stem base portion.Just there is generation in the disease seeding stage,
4, disease in May is stagnated, and the 6-9 month enters rainy season, into onset peak period.There are many types for root rot, it was reported that its symptom
Mostly caused by notoginseng root rot bacterium (Fusarium solani) (abbreviation F.solani).
This fungal disease is one of the main reason for causing Radix Notoginseng product quality for many years and yield to decline.In Guangxi three
Seven traditional Genuine producing area, due to low altitude area and the meteorological condition of high temperature and humidity, this disease is often simultaneous, causes
The a large amount of underproduction of Radix Notoginseng are even had no harvest, and are had brought tremendous economic losses to farmer.In order to control this fungal disease, greatly
The chemical pesticide of amount is used, and a large amount of pesticide residues of Radix Notoginseng product are caused, serious to polluted environment, is greatly threatened
People's health.Therefore, development biological control Radix Notoginseng fungal disease is very urgent to the sustainable development of Radix Notoginseng industry and must
It wants.The Antagonistic Fungi for filtering out energy while this disease of antagonism thus is of great significance, and screens and then develops and uses Antagonistic Fungi
It is also effectively to control one of most potential control measure of Radix Notoginseng fungal disease.
The information disclosed in the background technology section is intended only to increase the understanding to general background of the invention, without answering
When being considered as recognizing or imply that the information constitutes the prior art already known to those of ordinary skill in the art in any form.
Summary of the invention
The purpose of the present invention is to provide a kind of sophora tonkinensis Gapnep endogenetic bacteria B29 to prevent and treat the application in notoginseng root rot, from
And the notoginseng root rot occurred during energy effectively preventing notoginseng planting, to improve the yield and quality of Radix Notoginseng.
To achieve the above object, technical solution provided by the invention is as follows:
The classification naming of a kind of sophora tonkinensis Gapnep endogenetic bacteria B29, sophora tonkinensis Gapnep endophyte B29 are bulkholderia cepasea
(Burkholderia sp.) B29, the 16S rDNA gene order table of bacterial strain is as described in SEQ ID NO.1, depositary institution: China
Microbiological Culture Collection administration committee common micro-organisms center, preservation address: Yard 1, BeiChen xi Road, Chaoyang District, Beijing City 3
Institute of Microorganism, Academia Sinica, preservation date: on May 13rd, 2015, deposit number: CGMCC No.10807.
Preferably, the sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite the preparation method comprises the following steps: by sophora tonkinensis Gapnep endogenetic bacteria
B29 is inoculated in NB fluid nutrient medium, and being placed in temperature is 28 DEG C, fermented and cultured 10 days under the conditions of revolving speed is 130r/min, gained
Then fermentation material ultrasound 40min is extracted with ethyl acetate 2 times, ethyl acetate phase is taken to carry out being concentrated under reduced pressure to give strain fermentation object
Ethyl acetate extract, as sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite.
Preferably, the sophora tonkinensis Gapnep endogenetic bacteria B29 is inoculated in the fluid nutrient medium of NB containing 1000ml.
Preferably, NB fluid nutrient medium 3g containing beef extract, yeast extract 1g, peptone 5g, the sucrose 10g, training
Supporting base pH value is 7.0.
Application of the metabolite of sophora tonkinensis Gapnep endogenetic bacteria B29 as obtained by above-mentioned preparation in prevention and treatment notoginseng root rot.
Compared with prior art, the invention has the following beneficial effects:
The present invention for the first time from the root of medicinal plant sophora tonkinensis Gapnep separation screening to one plant of endogenetic bacteria (Burkholderia
Sp.) B29, the bacterium have very strong inhibiting effect to notoginseng root rot bacterium, bring for the field of biological control of Radix Notoginseng fungal disease
Wide application prospect.
Detailed description of the invention
Fig. 1 is the plate opposite culture of sophora tonkinensis Gapnep endogenetic bacteria B29 and notoginseng root rot of the present invention, and wherein F is Roots of Panax Notoginseng
Maize ear rot bacterium (Fusarium solani), a are blank control, and b is experimental group.
Fig. 2 is sophora tonkinensis Gapnep endogenetic bacteria B29 strain morphology feature of the present invention, wherein a1 is colonial morphology, and b1 is thallus shape
State.
Fig. 3 is the phylogenetic tree that sophora tonkinensis Gapnep endogenetic bacteria B29 bacterial strain is constructed based on 16S rDNA gene order.
Fig. 4 is that the metabolite of bacterial strain sophora tonkinensis Gapnep endogenetic bacteria B29 according to the present invention is raw to the mycelia of notoginseng root rot bacterium
Long inhibitory effect；Wherein the 1st, the 5th for blank control be not drug containing PDA plate；2nd, the 3rd, the 4th is positive control
Powder of carbendazim；6th, the 7th, the 8th is the metabolite of bacterial strain B29, and concentration is respectively 2mg/ml, 4mg/ml, 8mg/ml；F
For notoginseng root rot bacterium Fusarium solani.
Specific embodiment
It is described in detail With reference to embodiment, it is to be understood that protection scope of the present invention is not by specific
The limitation of embodiment.Experimental method used in following embodiments is conventional method unless otherwise specified.Following implementations
Material, reagent used in example etc., is commercially available unless otherwise specified.Ethyl acetate is that commercially available analysis is pure
Ethyl acetate.2X TagMasterMix is purchased from precious bioengineering Co., Ltd (Takara), and Primer-1, Primer-2 are by China
Big gene chemical synthesis.
Embodiment 1
Separation, the screening and identification of bacterial strain
One, the separation of bacterial strain
Material to be tested: the wild sophora tonkinensis Gapnep of Guangxi Tiandeng County In Limestone Area is picked up from.
Strains tested: it is provided by plant pathology research institute, Guangxi University.
Culture medium: 1000ml NA culture medium: beef extract 3g, yeast extract 1g, peptone 5g, sucrose 10g, agar 15g,
pH 7.0。
Surface sterilization: a length of 6-8cm, width is dry to rush for the sophora tonkinensis Gapnep root flowing water flushing 30min of 1-2cm fresh and healthy
Net silt air-dries surface moisture, superclean bench is moved on to, sterile then by clean sophora tonkinensis Gapnep root with rinsed with sterile water 2 times
Under the conditions of, by sophora tonkinensis Gapnep root volumetric concentration be 75% ethyl alcohol impregnate 1min, rinsed with sterile water 2 times, sodium hypochlorite (effective chlorine
1%) 2min is impregnated, sterile washing 3 times, it is spare that sterile blotting paper blots surface.
The separation of bacterial strain purifies: the good sophora tonkinensis Gapnep root of surface sterilization, under aseptic condition, scrapes off epidermis with sterile wood chip, uses
Sterile secateurs cuts off the both ends of sophora tonkinensis Gapnep root, and the sterile pocket knife of remaining part and aseptic nipper separate xylem and bast, point
The tissue block for not taking 0.5cm long is shredded with sterile secateurs and sterile water is added to grind, and after grinding sufficiently plus sterile water is settled to 5ml
And 10min is stood, take 0.5ml supernatant gradient dilution 10~105Times, take 100 μ L dilutions to be applied on NA plate respectively, often
A diluted concentration is repeated 3 times, and takes last time rinsing liquid to be coated on NA plate, as negative control.NA plate is placed in culture
28 DEG C of 24~96h of constant temperature incubation of case, picking different shape bacterium colony are crossed purifying repeatedly, will be raw thin in bacterial strain, that is, sophora tonkinensis Gapnep of purifying
Bacterium is saved with 20% glycerol.
The sophora tonkinensis Gapnep endogenetic bacteria being separated to is inoculated on LA plate, it is stand-by after being cultivated at 28 DEG C for 24 hours.By Radix Notoginseng root-rot
Germ is inoculated in PDA plate, stand-by after cultivating 3 days at 28 DEG C.
Two, it screens
Using tablet face-off method to the primary dcreening operation for carrying out thallus bacteriostatic activity for examination sophora tonkinensis Gapnep endogenetic bacteria.
Firstly, 6mm bacteria cake is made in notoginseng root rot bacterium with sterilization punchers under aseptic condition；In processing group, by three
Seven pine root fungus bacteria cakes are transferred to the center of the culture dish containing NA, then in the position apart from bacteria cake 2cm, the sophora tonkinensis Gapnep that will be separated to
Endogenetic bacteria bacterial strain connects a bacterium line, and every plant of endogenetic bacteria repeats 3 wares；In control group, notoginseng root rot bacterium bacterium is only connect
Cake does not connect sophora tonkinensis Gapnep endogenetic bacteria, repeats 3 wares.Then, it is cultivated at 28 DEG C, periodic observation.Training is covered with to fungi in control group
When supporting ware, in processing group, measurement notoginseng root rot bacterium bacteria cake center to Radix Notoginseng root-rot between sophora tonkinensis Gapnep endogenetic bacteria line center
The growth radius of germ is processing growth radius；In control group, the growth radius of notoginseng root rot bacterium is control growth radius.
Finally, according to the following formula, calculating bacteriostasis rate:
It compares increment=control and grows radius-bacteria cake radius
It handles increment=processing and grows radius-bacteria cake radius
As a result 3 plants are obtained to all very strong antagonism sophora tonkinensis Gapnep endogenetic bacteria bacterial strain of notoginseng root rot bacterium inhibiting effect,
In one plant of entitled B29, be 71% to the inhibiting rate of notoginseng root rot bacterium.
Three, it identifies
(1) strain morphology feature
Colony morphology characteristic observation: by strain inoculated to be identified on NA culture medium, 28 DEG C of cultures are placed in for 24 hours, observation
The colony morphology characteristic of bacterial strain.
Morphological features observation: taking the above-mentioned bacterial strain cultivated on NA culture medium for 24 hours to carry out Gram's staining and microscopy,
By observed form result microphotograph, as shown in Figure 2.
(2) bacterial strain 16S rDNA sequence and its phylogenetic analysis
The preparation of DNA profiling:
Reagent: (1) lysis buffer: 1% (w/ of Tris-Ac (pH 7.8) 40mM, NaAc 20mM, EDTA 1mM, SDS
v)；
(2) 5M NaCl solution.
DNA is extracted:
(a) 1.5ml overnight bacterial culture solution culture is placed in microcentrifugal tube (EP pipe), 12000rpm centrifugation
0.5min discards supernatant liquid, retains sediment；
(b) 400 μ l lysis buffers are added in sediment, is blown and beaten repeatedly with suction pipe and is allowed to be resuspended；
(c) 200ul 5M NaCl is added, mixes well, 12000rpm is centrifuged 10min, takes 600 μ l supernatants；
(d) isometric phenol/chloroform (1:1) is added, mixes, is centrifuged (12000rpm, 10min), supernatant is transferred to separately
In one clean EP pipe；
(e) isometric chloroform is added in the supernatant obtained into step (d), mixes, be centrifuged (12000rpm, 10min),
Supernatant is transferred in another clean EP pipe；
(f) isometric isopropanol is added in gained supernatant into step (e), mixes, is placed in room temperature 10min, be centrifuged
(12000rpm, 15min) discards supernatant liquid, retains sediment；
(g) it is 70% ethanol washing step (f) gained sediment with volumetric concentration, dries, as DNA；
(h) DNA done in step (g) is dissolved in 30 μ l distilled water (ddH2O in), -20 DEG C of preservations.
PCR amplification 16S rDNA sequence:
(1) PCR instrument: ABI 3730-XL DNA sequencer (Applied Biosystems, USA)；
(2) amplimer: 27F (5 '-AGAGTTTGATCCTGGCTCAG-3 ') is as shown in SEQ ID NO.2 and 1492R
(5 '-GGTTACCTTGTTACGACT-3 ') are as shown in SEQ ID NO.3；
(3) amplification system:
16S rDNA sequence PCR amplification system is as shown in table 1:
Table 1.
| Reactant | Sample-adding amount |
| 2X TagMasterMix | 25μL |
| Primer-1 | 1μL |
| Primer-2 | 1μL |
| Template DNA | 0.5μL |
| ddH2O | 22.5μL |
| React total volume | 50μL |
Note: the Template DNA in table 1 is that DNA profiling is made in DNA obtained by above-mentioned steps (h).
PCR reaction condition is as shown in table 2:
Table 2.
Note: step 2 carries out 30 circulations in table 2.
The electrophoresis detection of pcr amplification product:
The Ago-Gel (the 5 μ l/100ml containing Goldview) that deposition condition is 1%, 1 × TBE electrophoretic buffer, 90V
Electrophoresis 1 hour, PCR product applied sample amount was 3 μ L, point sample after mixing with 1 μ L Loading dye.In the ultraviolet lower sight of 254nm
It examines as a result, determining expanding fragment length using the DL1000DNA Marker of TaKaRa company as nucleic acid standard molecular weight object of reference.
Amplified production band should be on the position of reference substance 400-700bp.
PCR product purifying and sequencing: it is carried out by Shenzhen Huada Genetic Technology Co., Ltd.
The building of systematic evolution tree:
The 16S rDNA sequence of the bacterium measured in the 16S rDNA sequence surveyed and GenBank gene pool is compared
It is right, recall the 16S rDNA sequence with the higher bacterial strain of its sequence homology.Homologous sequence is carried out using Clustal-W software
More matching arrangements, the building systematic evolution tree of systematic evolution tree are carried out by 6.0 software of MEGA, as shown in Figure 3.
As a result:
(1) strain morphology feature
Colony morphology characteristic: bacterial strain bacterium colony is in yellow green on NA plate, and surface is smooth, protuberance, and neat in edge is round,
It is 1-2mm that 5 days diameters are cultivated on NA plate, as shown in a1 in Fig. 2.
Morphological features: Gram-negative is negative staining, no gemma, thallus direct rod shape, and size is (0.41~0.45) μ
M × (0.96~1.29) μm, as shown in b1 in Fig. 2.
(2) bacterial strain 16S rDNA sequence and its phylogenetic analysis
Using primer 2 7F and 1492R, the segment of a 1300-1400bp is amplified from strain gene group DNA, through surveying
Sequence is simultaneously compared sequencing result by BLASTn in GenBank, utilizes the adjoining algorithm (Neighbor-joining of MEGA6
NJ it) carries out network analysis and constructs systematic evolution tree.The result shows that 16S rDNA sequence and Burkholderia
The corresponding sequence homology of sp.SAP27_1 reaches 99%.Comprehensive morphological and molecular biological characteristics, by bacterial strain Preliminary Identification
For Burkholderia sp..
Embodiment 2
Inhibiting effect of the sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite to notoginseng root rot bacterium
One, the extraction of the fermented and cultured of bacterial strain and metabolite
Sophora tonkinensis Gapnep endogenetic bacteria B29 is inoculated in the fluid nutrient medium of NB containing 1000ml (beef extract 3g, yeast extract 1g, egg
White peptone 5g, sucrose 10g, pH 7.0) 2 liters of conical flasks in, be placed in the training of temperature is 28 DEG C, revolving speed is 130r/min shaker fermentation
It supports 10 days, then gained fermentation material ultrasonic echography 40min is extracted with ethyl acetate 2 times, take gained ethyl acetate phase twice
It is concentrated under reduced pressure to give the ethyl acetate extract of strain fermentation object, as sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite.
Two, inhibiting effect of the sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite to the mycelia growth of notoginseng root rot bacterium
Ethyl acetate extract with mycelia growth method measurement bacterial strain is sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite, right
The inhibitory activity of notoginseng root rot bacterium mycelia growth,.Respectively by the metabolite of bacterial strain B29 and powder of carbendazim (positive control)
It is made containing 2mg/mL, 4mg/mL, the drug containing tablet of the metabolite of 8mg/mL concentration B29.It aseptically, will with punch
6mm bacteria cake is made in disease fungus, and notoginseng root rot bacterium bacteria cake is connected to each drug containing tablet center for processing, in not drug containing tablet
Entreating the notoginseng root rot bacterium bacteria cake connect is negative control, and in triplicate, all plates are placed in 28 DEG C of cultures for all processing and control.
Drug concentration is arranged by the Field information concentration of powder of carbendazim.When negative control covers with culture dish, measurement compares bacterium respectively
The growth diameter of bacterium colony is fallen and is handled, and according to the following formula, calculates inhibiting rate:
Negative control increment=negative control growth diameter-bacteria cake diameter
Handle increment=processing growth diameter-bacteria cake diameter
Three, minimal inhibitory concentration of the sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite to notoginseng root rot bacterium
With the metabolite of broth dilution method determination bacterial strain B29 to the minimal inhibitory concentration of notoginseng root rot bacterium.PDA is trained
Feeding 5 days notoginseng root rot bacterium pure culture biscuits involvng inoculations are in the PDB fluid nutrient medium containing 0.2% Tween 80 (v/v), and 28 DEG C, 150r/
Min shaking table culture 7 days, culture is then gone into triangular flask, and pours into the aseptic double-distilled water containing 0.2% Tween 80, with magnetism
Stick stirs 30min, and solution is filtered with sterile gauze, obtains spores solution, and arrived spore concentration adjusting with blood counting chamber
Every milliliter 104A spore is spare.By the metabolite of bacterial strain B29 with 1%DMSO be dissolved into 80mg/mL metabolite processing it is dense
Degree, takes 5 sterile test tubes to be sequentially arranged on rack for test tube, and number is 1,2,3,4,5 respectively, and every pipe is separately added into 1ml containing 0.2%
Then the aseptic double-distilled water of Tween 80 the metabolite solution of the bacterial strain of 1ml 80mg/mL is added in the test tube that number is 1 simultaneously
Twice of serial dilution is successively carried out in each pipe.The above-mentioned gained spores solution (10 of 1ml4A/ml) it is separately added into each pipe, thus
The metabolite concentration for the treatment of of final B29: 20mg/ml (1 test tube of number) is obtained, 10mg/ml (2 test tube of number), 5mg/ml (are compiled
Number 3 test tubes), 2.5mg/ml (4 test tube of number), 1.25mg/ml (5 test tube of number).The 8mg/mL fluorine of the 1%DMSO and 1ml of 1ml
Silicon azoles missible oil replace the metabolite of B29 to execute above-mentioned treatment process respectively and as negative control and positive control, all places
Reason and control are in triplicate.Finally, 28 DEG C of each pipe, 150r/min shaking table culture 5 days.The metabolism of sophora tonkinensis Gapnep endogenetic bacteria B29 produces
The MIC value of object is the minimum crude extract concentration for completely inhibiting notoginseng root rot bacterium visible growth.
As a result:
In the percent inhibition such as table 3 that bacterial strain sophora tonkinensis Gapnep endophyte B29 metabolite grows notoginseng root rot bacterium mycelia
It is shown:
Table 3.
Note: positive control powder of carbendazim contains 50% carbendazim in table；* indicates that data pass through one-way analysis of variance in table
LSD relatively after, the metabolite and positive control powder of carbendazim of bacterial strain B29 is under same concentrations, in P0.05Have in level
Significant difference.
The suppression result that the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B29 grows notoginseng root rot bacterium mycelia shows bacterium
The metabolite of strain sophora tonkinensis Gapnep endophyte B29 all has extraordinary inhibitory effect to the mycelia growth of notoginseng root rot bacterium, from
Table 3 is it can be seen that the metabolite of B29 is 71.56- to the percent inhibition that notoginseng root rot bacterium F.solani mycelia grows
100%.Compared with positive control powder of carbendazim, the metabolite of bacterial strain B29 is raw to notoginseng root rot bacterium F.solani mycelia
Long inhibitory effect is slightly below compareed when concentration is less than or equal to 4mg/mL, equivalent with compareing in concentration 8mg/mL.
The minimal inhibitory concentration that bacterial strain B29 metabolite grows notoginseng root rot bacterium is as shown in table 4:
Table 4.
| Processing | MIC(mg/ml) |
| F.solani | |
| Flusilazole | 0.5 |
| B29 | 2.5 |
Note: positive control Flusilazole active constituent content is 400mg/mL in table.
The minimal inhibitory concentration test result that the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B29 grows notoginseng root rot bacterium
Show that the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B29 all has stronger inhibiting effect to notoginseng root rot bacterium, it can from table 4
To find out the metabolite of sophora tonkinensis Gapnep endophyte B29 to the minimal inhibitory concentration of notoginseng root rot bacterium F.solani for 2.5mg/
Ml is 5 times of positive control.
As may be known from Table 3 and Table 4, very strong restraining epiphyte is contained in the metabolite of bacterial strain sophora tonkinensis Gapnep endophyte B29 or is killed true
The ingredient of bacterium, therefore, in the bionomic control of notoginseng root rot bacterium, bacterial strain sophora tonkinensis Gapnep endophyte B29 has potentiality outstanding.
The aforementioned description to specific exemplary embodiment of the invention is in order to illustrate and illustration purpose.These descriptions
It is not wishing to limit the invention to disclosed precise forms, and it will be apparent that according to the above instruction, can much be changed
And variation.The purpose of selecting and describing the exemplary embodiment is that explaining specific principle of the invention and its actually answering
With so that those skilled in the art can be realized and utilize a variety of different exemplary implementation schemes of the invention and
Various chooses and changes.The scope of the present invention is intended to be limited by claims and its equivalents.
Claims (1)
1. a kind of application of metabolite of sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot, it is characterised in that: described
The classification naming of sophora tonkinensis Gapnep endophyte B29 is bulkholderia cepasea (Burkholderia sp.) B29, deposit number: CGMCC
No.10807；
The preparation method of the metabolite of the sophora tonkinensis Gapnep endogenetic bacteria B29: sophora tonkinensis Gapnep endogenetic bacteria B29 is inoculated in
In 1000ml NB fluid nutrient medium, being placed in temperature is 28 DEG C, fermented and cultured 10 days under the conditions of revolving speed is 130r/min, gained hair
Ferment object ultrasound 40min, is then extracted with ethyl acetate 2 times, and ethyl acetate phase is taken to carry out being concentrated under reduced pressure to give strain fermentation object
Ethyl acetate extract, as sophora tonkinensis Gapnep endogenetic bacteria B29 metabolite；Contain beef in the NB fluid nutrient medium of the 1000ml
Medicinal extract 3g, yeast extract 1g, peptone 5g, sucrose 10g, Medium's PH Value 7.0.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510979400.6A CN105462893B (en) | 2015-12-23 | 2015-12-23 | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510979400.6A CN105462893B (en) | 2015-12-23 | 2015-12-23 | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105462893A CN105462893A (en) | 2016-04-06 |
| CN105462893B true CN105462893B (en) | 2019-02-26 |
Family
ID=55601055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510979400.6A Active CN105462893B (en) | 2015-12-23 | 2015-12-23 | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105462893B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105462896B (en) * | 2015-12-23 | 2019-02-26 | 广西大学 | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment Alternaria panax |
| CN105462894B (en) * | 2015-12-23 | 2019-07-16 | 广西大学 | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment Radix Notoginseng anthracnose |
| CN112646754B (en) * | 2021-01-22 | 2023-04-07 | 云南农业大学 | Burkholderia and application thereof in preventing and treating main pathogenic bacteria of panax notoginseng root rot |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010018371A2 (en) * | 2008-08-13 | 2010-02-18 | University College Cardiff Consusltants Ltd | Antimicrobial agent and method for the production thereof |
| KR101175532B1 (en) * | 2011-10-07 | 2012-08-22 | 나윤경 | Novel burkholderia sp., and media for mass culture of burkholderia for increasing antifungal effect and method for mass production thereof using the same |
| CN103478147A (en) * | 2013-10-09 | 2014-01-01 | 山东省科学院中日友好生物技术研究中心 | Granule of Burkholderia vietnamiensis P418 nematicidal active substances and preparation thereof |
-
2015
- 2015-12-23 CN CN201510979400.6A patent/CN105462893B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010018371A2 (en) * | 2008-08-13 | 2010-02-18 | University College Cardiff Consusltants Ltd | Antimicrobial agent and method for the production thereof |
| KR101175532B1 (en) * | 2011-10-07 | 2012-08-22 | 나윤경 | Novel burkholderia sp., and media for mass culture of burkholderia for increasing antifungal effect and method for mass production thereof using the same |
| CN103478147A (en) * | 2013-10-09 | 2014-01-01 | 山东省科学院中日友好生物技术研究中心 | Granule of Burkholderia vietnamiensis P418 nematicidal active substances and preparation thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105462893A (en) | 2016-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104630071B (en) | Spore trichoderma and its application more than one plant | |
| CN104694397B (en) | One plant of chaetomium globosum and its application | |
| CN105462850B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus SDTE-P in prevention and treatment notoginseng root rot | |
| CN105483020B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-34-1 in prevention and treatment notoginseng root rot | |
| CN105462893B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment notoginseng root rot | |
| CN105462890B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B22 in prevention and treatment notoginseng root rot | |
| CN105483041B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B22 in prevention and treatment Alternaria panax | |
| CN105462892B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment Alternaria panax | |
| CN105462847B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-46 in prevention and treatment notoginseng root rot | |
| CN105462854B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus SDTE-P in prevention and treatment Radix Notoginseng anthracnose | |
| CN105462896B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment Alternaria panax | |
| CN105462891B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment notoginseng root rot | |
| CN105462895B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B22 in prevention and treatment Radix Notoginseng anthracnose | |
| CN105462897B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B21 in prevention and treatment Radix Notoginseng anthracnose | |
| CN104962501B (en) | A kind of preparation and application of the bacterial strain, antagonist of anti-vegetable and fruit gray mold | |
| CN104593266B (en) | A kind of Endophytic Fungi in Tomato intertexture branch top spore and its application in tomato root-knot eelworm diease occurrence is anti- | |
| CN105462894B (en) | Application of the sophora tonkinensis Gapnep endogenetic bacteria B29 in prevention and treatment Radix Notoginseng anthracnose | |
| CN114134053B (en) | Aspergillus ascomycete MR-86 and application thereof | |
| CN105462849B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-46 in prevention and treatment Alternaria panax | |
| CN105462851B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-59-2 in prevention and treatment notoginseng root rot | |
| CN105483022B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-34-1 in prevention and treatment Alternaria panax | |
| CN114990020A (en) | Biocontrol strain and application thereof | |
| CN105483021B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-34-1 in prevention and treatment Radix Notoginseng anthracnose | |
| CN105462853B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-59-2 in prevention and treatment Radix Notoginseng anthracnose | |
| CN105462852B (en) | Application of the sophora tonkinensis Gapnep endogenetic fungus TRXY-46 in prevention and treatment Radix Notoginseng anthracnose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |